Helping improve a member’s cancer care journey through coordinated care approach a cornerstone to putting the patient first, driving better quality, reducing drug costs, and improving medication adherence
Growing demand for specialty care, shifting prescriber habits, and new reimbursement models have forced stakeholders to adjust practices to optimize patient outcomes.
Walgreens Boots Alliance is investing $970 million for a majority stake in a specialty pharmacy company that works with hospitals and health systems to set up and run their own…
DEERFIELD, Ill. & BOSTON–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) and Shields Health Solutions today announced that WBA, through its wholly-owned subsidiary, Walgreen Co., is making a majority investment in…
The company will pay $970 million to increase its ownership of the Stoughton-based specialty pharmacy company to 71 percent
The COVID-19 pandemic has elevated the urgency of addressing health equity and the role of social determinants of health (SDoH) in health disparities. The dynamism and growth of the specialty…
Specialty pharmacists’ roles have grown in new and exciting ways in recent years, and those changes have directly impacted health outcomes for all specialty patients, including patients with HIV.
As the ongoing shift to value-based care inspires health care providers to maximize efficiency, health systems with an integrated specialty pharmacy have established a model that can address specific inefficiencies…
MINNEAPOLIS–(BUSINESS WIRE)–Excelera®, a wholly-owned subsidiary of Shields Health Solutions and the company behind the Excelera Network, announced today a new specialty pharmacy-focused educational offering in partnership with Aptitude Health, which provides critical insights…